Piramal Pharma Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Piramal's expertise across varied technologies makes them a partner of choice for innovators & generic companies worldwide.
One of their notable products is LEVOKETOCONAZOLE, with a corresponding US DMF Number 38973.
Remarkably, this DMF maintains an Active status since its submission on October 18, 2023, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 23, 2025, and payment made on June 09, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II